Shuttle Pharmaceuticals

About:

Shuttle Pharmaceuticals is a clinical-stage pharmaceutical company utilizing proprietary technology to develop novel therapies.

Website: https://www.shuttlepharma.com

Description:

Shuttle Pharmaceuticals is a clinical-stage pharmaceutical company utilizing proprietary technology to develop novel therapies. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy. While there are several therapies being developed with the goal of curing cancer, one of the most effective and proven approaches to this is radiation therapy (RT).

Total Funding Amount:

$9.41M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Rockville, Maryland, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)shuttlepharma.com

Founders:

Anatoly Dritschilo

Number of Employees:

11-50

Last Funding Date:

2024-10-30

IPO Status:

Public

Industries:

© 2025 bioDAO.ai